Freudenberg Lutz S, Klett Rigobert, Fischer Manfred, Boddenberg-Pätzold Barbara, Tönshoff Gregor, Czech Norbert J, Kampen Willm Uwe
ZRN Rheinland und ZRN MVZ GmbH, Korschenbroich.
ÜBAG für Nuklearmedizin, Hanau-Frankfurt-Offenbach-Gießen, Gießen.
Nuklearmedizin. 2021 Jun;60(3):224-232. doi: 10.1055/a-1400-3537. Epub 2021 Mar 23.
Radiosynoviorthesis (RSO) is a local radionuclide therapy of inflammatory joint diseases, successfully performed since several decades mainly as an outpatient-protocol in ambulatory health care centers or nuclear medicine practices. Despite of long-term experience in some centers, only very few valuable or comparable data about the procedure itself and/or the clinical results of this treatment are available.
The aim of this online survey is to assess reliable data of the current status in Germany.
A web-based questionnaire was designed to evaluate the status of RSO in Germany including demographic data, training, pretherapeutic diagnostics, clinical procedures, and follow-up. The survey was distributed via the supplier of RSO-nuclides, national nuclear medicine societies, and personal networks. It was available for 28 days and closed on November 30, 2020.
A total of 78 specialists in nuclear medicine answered the questionnaire, which corresponds to a response rate of 23 %. Several differences and concordances in pre-therapeutic diagnostics, in the procedure of RSO itself, and follow-up were documented in this survey for the first time. Most important, less than 70 nuclear medicine specialists in Germany perform more than 75 % of all RSO-procedures and most of them are older than 50 years of age. This implies the urgent need of a dedicated advancement of young academics in nuclear medicine and a professional advanced training in RSO to offer this beneficial treatment to future patients.
To achieve these goals, an association of RSO experts would be useful, through which, among other things, an RSO training curriculum is developed and theoretical and practical trainings are organized. Moreover, possible cooperation agreements between ambulant and inpatient institutions would foster the education of young nuclear medicine specialists interested in RSO.
放射性滑膜切除术（RSO）是一种用于治疗炎性关节疾病的局部放射性核素疗法，几十年来已成功开展，主要作为门诊方案在门诊医疗中心或核医学科室实施。尽管一些中心有长期经验，但关于该治疗本身和/或临床结果的有价值或可比较的数据却非常少。
本次在线调查旨在评估德国的当前可靠数据。
设计了一份基于网络的问卷，以评估德国RSO的现状，包括人口统计学数据、培训、治疗前诊断、临床操作和随访。该调查通过RSO核素供应商、国家核医学协会和个人网络进行分发。问卷开放28天，于2020年11月30日截止。
共有78名核医学专家回答了问卷，回复率为23%。本次调查首次记录了治疗前诊断、RSO本身的操作以及随访方面的一些差异和一致性。最重要的是，德国不到70名核医学专家实施了所有RSO操作的75%以上，其中大多数年龄超过50岁。这意味着迫切需要专门推动年轻核医学专业人员的发展，并对RSO进行专业进阶培训，以便为未来的患者提供这种有益的治疗。
为实现这些目标，成立RSO专家协会将很有帮助，通过该协会，除其他事项外，还可制定RSO培训课程并组织理论和实践培训。此外，门诊和住院机构之间可能达成的合作协议将促进对RSO感兴趣的年轻核医学专家的教育。
